Masimo Corp (MASI) - Cumulative Company Assets

Public company logo of Masimo Corp (MASI)

Specialized transportation of precision equipment ensures the reliability of devices in intensive care units, and this growth in assets and resources on the GURU.Markets system chart provides confirmation of capitalization. The value of 685.12 reflects the latest metric value. The stability of Masimo Corporation (MASI) is based on the patent protection of pulse oximetry, while expansion into the wearable electronics segment reduces dependence on government procurement.

Masimo Corp (MASI) Company Total Assets: for the period 07/04/2022 - 06/21/2026

Comprehensive metric breakdowns and analytics for Masimo Personal Health (MASI)

- price and consensus price forecast:
Market Chart masimo.com|MASI - Price Target Chart
- market capitalization data:
Market Valuation Masimo Inc.|MASI - Enterprise Value
- book capitalization data:
Net Asset Value per Share Masimo|MASI - Book Capitalization|Capitalization to Book Value Ratio masimo.com|MASI - Company Total Assets
- debt and liquidity data:
Total Debt to Capital Coefficient Masimo Corporation|MASI - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Masimo Inc.|MASI - Company Aggregate Debts|Debts to Book Capitalization Masimo Inc.|MASI - Company Long-Term Debt|Company Short-Term Debt Masimo
Fundamental valuation:masimo.com, MASI
Manufactured product of Masimo Corporation

Calculating the metric via a reverse ROA formula allows for the elimination of volatility and the precise determination of the total value of resources controlled by Masimo Corporation (MASI). The positive trend in total assets confirms the expansion of the material base, which, coupled with certified component outsourcing, minimizes operational risks and demonstrates sustainable business scaling without critical dependence on individual suppliers.

Main competitors

ISRG (intuitive.com) - Company Total Asset Base|Aggregate Company Assets DHR|Cumulative Company Assets BD|STERIS Corporation - Company Total Assets|Company Assets West Pharma Corp (WST)|BAX - Company Total Assets|Total Business Assets stevanatogroup.com STVN|Company Total Assets TFX (Teleflex)|MMSI - Company Total Asset Base|NVST (Envista Holdings Corp) - Company Total Assets|ICU Medical Inc. (ICUI) - Cumulative Company Assets|XRAY (DENTSPLY SIRONA Inc.) - Company Total Assets|Company Total Assets LMAT|Aggregate Company Assets AtriCure (ATRC)|Aggregate Company Assets STAAR Surgical Co. STAA|Cumulative Company Assets niagenbioscience.com|Aggregate Asset Value ZimVie Corp ZIMV|Company Total Assets ANGO (AngioDynamics, Inc.)|CERS: Company Total Asset Base|Aggregate Company Assets Teknova|MGRM (Monogram Technologies Inc.) - Total Business Assets|STSS: Aggregate Company Assets|Company Total Asset Base InfuSystem Inc (INFU)|Cumulative Company Assets Utah Medical Products|Aggregate Business Assets KRMD (korumedical.com)|Aggregate Company Assets Nyxoah|MBOT - Aggregate Asset Value|Pro-Dex Corp - Cumulative Company Assets|ZTEK: Company Total Assets|ELUT (Elutia Inc.) - Aggregate Company Assets|milestonescientific.com (MLSS) - Cumulative Company Assets|Company Total Assets NXGL (NEXGEL)|Company Assets RVP|Aggregate Company Assets Harvard Bioscience HBIO|Total Business Assets Femasys Corporation FEMY|Cumulative Company Assets Meihua Medical Technologies Co., Ltd. (MHUA)|Predictive Oncology Inc - Aggregate Business Assets|Aggregate Company Assets CJMB (Callan JMB Corp)|ATRI: Company Total Asset Base|NURO (NeuroMetrix Corp) - Aggregate Company Assets